Drug Testing Basics Explained

What’s covered

What drug testing is and why it is done
Drug screen vs. drug test, the difference
All five specimen types and their use cases
Detection window table by substance and method
Result types: negative, positive, non-negative, inconclusive
False positives, the MRO process and GC/MS confirmation
Key terminology and how employer programs work

Fundamentals

What is drug testing?

The technical analysis of a biological specimen to detect the presence of drugs or their metabolites, the chemical byproducts left in the body after a substance is processed and partially eliminated.

The specimen analysed may be urine, blood, saliva, hair or sweat, depending on the purpose of the test, the substances being screened and the detection window required.

Why drug testing is done

Employers use drug testing to reduce workplace accidents, protect employees and customers, and comply with federal or state regulations. DOT-regulated industries, trucking, aviation, railroad, transit, are legally required to maintain drug and alcohol testing programs for safety-sensitive employees. Non-DOT employers may establish their own programs based on company policy, insurance requirements or industry standards.

Other common reasons include pre-employment screening, random deterrence programs, post-accident investigations, reasonable suspicion testing when impairment is observed, and court-ordered or probation monitoring.

Drug screen vs. drug test, understanding the difference

These terms are often used interchangeably but refer to different stages of the process. A drug screen (also called an immunoassay screen) is an initial, rapid analysis that indicates whether a specimen may contain drugs above a threshold level. It is fast and cost-effective, but less specific, and can produce false positive results when medications or other substances cross-react with the test reagents.

A drug test in the confirmatory sense refers to the more precise follow-up analysis, typically gas chromatography/mass spectrometry (GC/MS), used to confirm non-negative screen results. GC/MS identifies the exact substance present and its concentration, eliminating cross-reactivity errors. For certified workplace testing programs, confirmatory testing is required before any positive result can be reported to an employer.

A screen is not a final result.

A non-negative screen result does not mean a positive violation. It means the specimen requires confirmatory testing. The Medical Review Officer reviews confirmed non-negative results, contacts the donor about any legitimate medical explanation, and issues the final verified result. Only after MRO review is a result reported to the employer.

Glossary

Key terminology

MetaboliteThe chemical byproduct left in the body after a substance is processed
ImmunoassayRapid initial screening method used for first-pass detection
GC/MSGas chromatography/mass spectrometry, the gold standard for confirmation
MROMedical Review Officer, licensed physician who reviews non-negative results
Chain of custodyDocumented trail proving specimen integrity from collection to result
Cutoff levelThe concentration threshold above which a result is reported as non-negative

Start to finish

The testing process

Specimen collected under certified chain-of-custody procedures
Initial immunoassay screen performed
Non-negative screens sent for GC/MS confirmatory testing
MRO reviews confirmed non-negatives and contacts the donor
Final verified result reported to employer or requesting party

Specimen types

The five drug testing specimen types

Each has different advantages, limitations, detection windows and appropriate use cases. The choice of specimen directly affects what the test can and cannot detect.

1–30+ days

Urine

The most widely used specimen for workplace testing, non-invasive, cost-effective and capable of detecting a broad range of substances. Required by DOT for all federal programs. Detects metabolites rather than the drug itself, which is why detection windows extend beyond the period of impairment.

24–48 hours

Saliva (oral fluid)

Non-invasive and difficult to adulterate. Detects parent drugs rather than metabolites, which means it reflects more recent use and correlates better with current impairment. Increasingly used for post-accident and reasonable suspicion testing.

Up to 90 days

Hair follicle

The longest detection window of any specimen type, roughly 90 days of history from a standard 1.5-inch sample. Cannot detect very recent use within the past 5–7 days while the hair grows. Used when long-term patterns matter more than recency.

Hours to 1–2 days

Blood

The most accurate picture of drug concentration at the time of testing, valuable in legal proceedings and post-accident investigations where proving current impairment matters. More invasive and expensive, and requires trained phlebotomy personnel.

Days to weeks

Sweat (patch)

A patch worn on the skin continuously collects sweat over 7–14 days, then is analysed for drug presence. Less common in standard workplace testing, but used in probation monitoring, court-ordered supervision and treatment programs.

Which is right?

Depends on your program goal

Most employer programs use urine, accepted for DOT compliance with broad substance coverage at low cost. Oral fluid is growing for roadside and post-accident use. Hair is used when historical use matters more than recency. We provide urine and oral swab testing.

Detection windows

How long do drugs stay detectable?

Windows vary significantly by substance, specimen type, frequency of use, individual metabolism and body composition. The ranges below represent typical detection for occasional to regular users.

Typical detection windows by substance and specimen type. Heavy chronic use can significantly extend these ranges.
Substance	Urine	Saliva	Blood	Hair
Marijuana (THC)	1–30 days (up to 90 heavy)	24–72 hours	2–7 days	Up to 90 days
Cocaine	2–4 days	1–2 days	12–24 hours	Up to 90 days
Opiates (codeine, morphine)	1–3 days	1–4 days	12 hours	Up to 90 days
Amphetamines / meth	1–4 days	1–3 days	24–48 hours	Up to 90 days
Phencyclidine (PCP)	7–14 days	1–3 days	24 hours	Up to 90 days
Benzodiazepines	3 days – 6 weeks	1–5 days	24–48 hours	Up to 90 days
Barbiturates	2 days – 3 weeks	1–2 days	1–3 days	Up to 90 days
Methadone	3–12 days	1–3 days	24–36 hours	Up to 90 days
Alcohol	7–12 hours (urine ethanol)	12–24 hours	3–10 hours	Not typical

Detection windows are estimates, not guarantees.

These ranges are general estimates for occasional to moderate users. Chronic daily use, higher body fat percentage (which stores THC longer), slower metabolism and high doses can all significantly extend detection. Conversely, infrequent use of short-acting substances may clear faster than the low end of the range. Detection windows should not be used to predict when a test will return negative, individuals metabolise substances differently.

Understanding results

What drug test results mean

Results fall into a few categories. Understanding what each means, and what happens next, is essential for both employers and individuals.

No action required

Negative

No drugs were detected above the established cutoff level.

No drugs detected above cutoff thresholds
MRO confirms and reports as negative
No further action required by the employer
Results typically within 24–48 hours for urine

Violation, action required

Positive (verified)

Drugs were detected above the cutoff, confirmed by GC/MS and verified by the MRO after the donor had the opportunity to explain any legitimate medical reason.

GC/MS confirmatory test completed
MRO contacted the donor, no valid medical explanation
Result reported to the employer as a verified positive
DOT: driver removed from safety-sensitive duties immediately and the violation reported to the FMCSA Clearinghouse

Further review required

Non-negative / inconclusive

The initial screen detected a substance above screening thresholds, but the result has not yet been confirmed. “Non-negative” is not the same as “positive”.

GC/MS confirmation testing initiated
MRO contacts the donor about prescriptions or medical explanations
A valid prescription may result in a verified negative outcome
Inconclusive results require recollection or additional testing

False positives & confirmatory testing

False positives, false negatives and the MRO process

Drug test accuracy is high, but not perfect. Initial immunoassay screens can produce false positives due to cross-reactivity, which is precisely why certified programs require confirmatory GC/MS testing before any positive result is reported.

Common causes of false positives

Ibuprofen and other NSAIDs cross-reacting with the amphetamine panel on some screens
Certain antihistamines and cold medications cross-reacting with methamphetamine screens
Quinolone antibiotics occasionally triggering opiate screens
Hemp-derived CBD products that contain trace THC above the cutoff level
Prescription benzodiazepines, opioids and stimulants triggering screens for their respective panels

GC/MS confirmatory testing eliminates virtually all false positives, it identifies the specific substance and its concentration with a precision immunoassay screens cannot achieve. This is why GC/MS is mandatory before any positive result is reported in certified testing programs.

The MRO review process

The Medical Review Officer is a licensed physician trained in drug testing who receives all non-negative laboratory results before they are reported to the employer. Before issuing a verified positive result, the MRO contacts the donor directly to determine whether there is a legitimate medical explanation, such as a valid prescription for a detected substance. If the donor provides adequate medical documentation, the MRO may verify the result as negative even if the lab confirmed the substance’s presence.

For DOT testing, the MRO process is a federal requirement. For non-DOT programs, MRO review is best practice and protects both the employer and the employee from false positive violations.

Always disclose prescriptions at intake, before the test.

If you take any prescription medications, especially opioids, benzodiazepines, stimulants or sedatives, disclose them at the collection site during intake. This creates a record prior to the test. The MRO will contact you if a non-negative result requires explanation, and prior disclosure helps the process go smoothly. Disclosing a prescription does not guarantee a negative result, but it ensures the MRO has context.

In summary

The MRO’s role

Receives all non-negative lab results before the employer does
Contacts the donor to discuss any medical explanation
Reviews prescription documentation if provided
Issues the final verified result, positive or negative
Protects employees from unfair violations due to legal medications

Variables

Factors that affect results

Individual metabolic rate and overall health
Body fat percentage: THC binds to fat cells
Frequency and quantity of use
Specimen collection timing relative to use
Cross-reactive medications or foods
Specimen temperature, handling and storage
Lab equipment calibration and the cutoff levels used

Key terminology

Drug testing terms everyone should know

These terms appear throughout testing documentation, results reports and employer policies.

ImmunoassayInitial screening method
A rapid antibody-based screening technique used to detect drug presence above a cutoff threshold. Fast and cost-effective, but not substance-specific, cross-reactivity with medications can produce false positives. Any non-negative immunoassay result must be confirmed by GC/MS before being reported as positive.
GC/MSGas chromatography / mass spectrometry
The gold-standard confirmatory testing method. GC/MS separates and identifies chemical compounds with extreme precision, it can distinguish between structurally similar substances and measure their exact concentration. Required for confirmatory testing in all certified programs.
Cutoff levelDetection threshold
The minimum concentration at which a substance must be present for the test to report a non-negative result. Below the cutoff, the result is reported as negative even if trace amounts are present. Cutoff levels are set by regulatory bodies (SAMHSA for federal programs) or by employers for non-DOT programs.
Chain of custodySpecimen documentation trail
The documented process that tracks a specimen from collection through laboratory analysis and result reporting. Each transfer is documented with signatures, timestamps and tamper-evident sealing. An unbroken chain of custody is required for results to be legally defensible.
MetaboliteDrug byproduct
The chemical compound produced when the body processes a drug. Most urine drug tests detect metabolites rather than the drug itself, which is why detection windows extend beyond the period of actual drug effects or impairment.
MROMedical Review Officer
A licensed physician with specialized training in drug testing who reviews all non-negative laboratory results before they are reported to employers. Required for all DOT testing programs.
SAMHSACertified laboratory standard
The Substance Abuse and Mental Health Services Administration, whose laboratory certification standards are required for all DOT drug testing. Only SAMHSA-certified laboratories are authorized to analyse specimens for federal workplace drug testing programs.
DOT vs. non-DOTRegulatory classification
DOT drug tests follow strict federal regulations under 49 CFR Part 40, including SAMHSA-certified labs, specific collection procedures, federal CCF forms and mandatory MRO review. Non-DOT tests follow employer-defined procedures. The two are not interchangeable.

Workplace drug testing programs

How employer drug testing programs work

A well-designed program includes clear policies, multiple test circumstances, consistent application and proper documentation.

Pre-employment testing

A drug test conducted before extending a final employment offer. The conditional offer is contingent on a negative result. Sets clear expectations and establishes a baseline for the program.

Random testing

Employees are selected unpredictably throughout the year using a scientifically random process. The unpredictability is the deterrent. DOT programs have minimum annual random testing rates by agency.

Post-accident testing

Conducted after a workplace accident to determine whether substance use was a contributing factor. DOT programs have specific triggering criteria and time windows; non-DOT employers define their own thresholds.

Reasonable suspicion

When a trained supervisor observes specific, articulable signs of impairment, the employee is tested. Documentation of the observed signs must occur before or immediately after the test. Requires supervisor training.

Return-to-duty & follow-up

After a violation, the employee must pass a return-to-duty test before resuming safety-sensitive work. Follow-up testing continues for a defined period, at least 6 tests in 12 months for DOT programs.

A written policy is required

A legally sound program requires a clear written policy communicated to all employees before testing begins, defining which test types are used, when, what substances are tested and the consequences of a positive result. Inconsistent application creates legal exposure.

What is drug testing?

Why drug testing is done

Drug screen vs. drug test, understanding the difference

Key terminology

The testing process

The five drug testing specimen types

Urine

Saliva (oral fluid)

Hair follicle

Blood

Sweat (patch)

Depends on your program goal

How long do drugs stay detectable?

What drug test results mean

Negative

Positive (verified)

Non-negative / inconclusive

False positives, false negatives and the MRO process

Common causes of false positives

The MRO review process

The MRO’s role

Factors that affect results

Drug testing terms everyone should know

How employer drug testing programs work

Pre-employment testing

Random testing

Post-accident testing

Reasonable suspicion

Return-to-duty & follow-up

A written policy is required

Drug testing services we provide in Kansas City

5 panel drug testing

9 panel drug testing

10 panel drug testing

DOT drug & alcohol testing

Certified drug testing in Kansas City